• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

肺动脉高压合并新型冠状病毒肺炎患者的意外康复：病例系列

An unexpected recovery of patients with pulmonary arterial hypertension and SARS-CoV-2 pneumonia: a case series.

作者信息

Scuri Piermario, Iacovoni Attilio, Abete Raffaele, Cereda Alberto, Grosu Aurelia, Senni Michele

机构信息

Department of Cardiology, ASST Ospedale Papa Giovanni XXIII, Bergamo, Italy.

Department of Cardiology, Policlinico di Monza, Monza, Italy.

出版信息

Pulm Circ. 2020 Sep 21;10(3):2045894020956581. doi: 10.1177/2045894020956581. eCollection 2020 Jul-Sep.

DOI:10.1177/2045894020956581
PMID:33014337
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7509751/
Abstract

Since the beginning of the SARS-CoV-2 outbreak, few cases of COVID-19 pneumonia in patients with pulmonary arterial hypertension have been reported. We present four patients with known history of PAH admitted to our hospital with SARS-CoV-2 pneumonia to analyze the impact of this disease on their clinical outcome.

摘要

自新型冠状病毒肺炎（COVID-19）疫情爆发以来，肺动脉高压患者中COVID-19肺炎的病例报告较少。我们报告了4例已知患有肺动脉高压（PAH）病史的患者，因感染SARS-CoV-2肺炎入住我院，以分析这种疾病对其临床结局的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0054/7509751/568ba2f5604b/10.1177_2045894020956581-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0054/7509751/568ba2f5604b/10.1177_2045894020956581-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0054/7509751/568ba2f5604b/10.1177_2045894020956581-fig1.jpg

相似文献

1
An unexpected recovery of patients with pulmonary arterial hypertension and SARS-CoV-2 pneumonia: a case series.肺动脉高压合并新型冠状病毒肺炎患者的意外康复：病例系列
Pulm Circ. 2020 Sep 21;10(3):2045894020956581. doi: 10.1177/2045894020956581. eCollection 2020 Jul-Sep.
2
COVID-19 in Pulmonary Artery Hypertension (PAH) Patients: Observations from a Large PAH Center in New York City.肺动脉高压（PAH）患者中的新型冠状病毒肺炎（COVID-19）：来自纽约市一家大型PAH中心的观察结果
Diagnostics (Basel). 2021 Jan 15;11(1):128. doi: 10.3390/diagnostics11010128.
3
Late Reactivation of SARS-CoV-2: A Case Report.严重急性呼吸综合征冠状病毒2型的晚期再激活：一例报告
Front Med (Lausanne). 2020 Aug 20;7:531. doi: 10.3389/fmed.2020.00531. eCollection 2020.
4
Potential Effect of COVID-19 on Maternal and Infant Outcome: Lesson From SARS.新型冠状病毒肺炎对母婴结局的潜在影响：借鉴严重急性呼吸综合征的经验教训
Front Pediatr. 2020 Aug 7;8:511. doi: 10.3389/fped.2020.00511. eCollection 2020.
5
The course of COVID-19 in a 55-year-old patient diagnosed with severe idiopathic pulmonary arterial hypertension.一名55岁被诊断为重度特发性肺动脉高压患者的新冠肺炎病程。
Pulm Circ. 2020 Jul 28;10(3):2045894020936659. doi: 10.1177/2045894020936659. eCollection 2020 Jul-Sep.
6
Analysis of SARS-CoV-2 Screening Clinic (Including Drive-Through System) Data at a Single University Hospital in South Korea from 27 January 2020 to 31 March 2020 during the COVID-19 Outbreak.2020年1月27日至2020年3月31日新冠疫情期间，韩国一家大学医院SARS-CoV-2筛查诊所（包括免下车系统）数据的分析。
Healthcare (Basel). 2020 May 26;8(2):145. doi: 10.3390/healthcare8020145.
7
Accelerated Pulmonary Ossification as a Sequela of SARS-CoV-2 Pneumonia.加速性肺骨化作为新型冠状病毒肺炎的后遗症
Radiol Cardiothorac Imaging. 2021 Apr 1;3(2):e200598. doi: 10.1148/ryct.2021200598. eCollection 2021 Apr.

引用本文的文献

1
The Impact of COVID-19 Infection on Patients with Severe Chronic Pulmonary Hypertension: A Prospective Study from a Single Referral Center.COVID-19 感染对严重慢性肺动脉高压患者的影响：来自单一转诊中心的前瞻性研究。
Medicina (Kaunas). 2024 Apr 30;60(5):750. doi: 10.3390/medicina60050750.
2
Pulmonary hypertension outcomes during the COVID-19 pandemic in Brazil.巴西新冠疫情期间的肺动脉高压治疗结果
J Bras Pneumol. 2023 Nov 17;49(5):e20230020. doi: 10.36416/1806-3756/e20230020.
3
Impact of the COVID-19 pandemic on chronic disease management and patient reported outcomes in patients with pulmonary hypertension: The Pulmonary Hypertension Association Registry.

本文引用的文献

1
Could pulmonary arterial hypertension patients be at a lower risk from severe COVID-19?肺动脉高压患者患重症 COVID-19 的风险会更低吗？
Pulm Circ. 2020 Apr 27;10(2):2045894020922799. doi: 10.1177/2045894020922799. eCollection 2020 Apr-Jun.
2
Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19.新冠病毒肺炎住院患者治疗剂量抗凝与院内生存的相关性
J Am Coll Cardiol. 2020 Jul 7;76(1):122-124. doi: 10.1016/j.jacc.2020.05.001. Epub 2020 May 6.
3
Reacquainting Cardiology With Mechanical Ventilation in Response to the COVID-19 Pandemic.
2019年冠状病毒病大流行对肺动脉高压患者慢性病管理及患者报告结局的影响：肺动脉高压协会注册研究
Pulm Circ. 2023 Apr 1;13(2):e12233. doi: 10.1002/pul2.12233. eCollection 2023 Apr.
4
The Evolving Management and Treatment Options for Patients with Pulmonary Hypertension: Current Evidence and Challenges.肺动脉高压患者的治疗管理选择：当前的证据和挑战。
Vasc Health Risk Manag. 2023 Mar 3;19:103-126. doi: 10.2147/VHRM.S321025. eCollection 2023.
5
Management of COVID-19 in Patients with Pulmonary Arterial Hypertension.COVID-19 患者的肺动脉高压管理。
Heart Fail Clin. 2023 Jan;19(1):107-114. doi: 10.1016/j.hfc.2022.07.003. Epub 2022 Aug 10.
6
The COVID-19 pandemic and pulmonary arterial hypertension in Italy: adaptation, outcomes and valuable lessons learned.意大利的 COVID-19 大流行与肺动脉高压：适应、结果和宝贵经验教训。
Eur Respir J. 2022 Oct 6;60(4). doi: 10.1183/13993003.00796-2022. Print 2022 Oct.
7
The Platelet-Derived Growth Factor Pathway in Pulmonary Arterial Hypertension: Still an Interesting Target?血小板衍生生长因子通路在肺动脉高压中的作用：仍是一个有趣的靶点吗？
Life (Basel). 2022 Apr 29;12(5):658. doi: 10.3390/life12050658.
8
COVID-19 in Patients with Pulmonary Hypertension: A National Prospective Cohort Study.COVID-19 与肺动脉高压患者：一项全国性前瞻性队列研究。
Am J Respir Crit Care Med. 2022 Sep 1;206(5):573-583. doi: 10.1164/rccm.202112-2761OC.
9
Recent advancements in pulmonary arterial hypertension and right heart failure research: overview of selected abstracts from ATS2020 and emerging COVID-19 research.肺动脉高压与右心衰竭研究的最新进展：美国胸科学会2020年会议部分摘要综述及新型冠状病毒肺炎相关研究新进展
Pulm Circ. 2021 Aug 19;11(3):20458940211037274. doi: 10.1177/20458940211037274. eCollection 2021 Jul-Sep.
10
The Combination of Chest Computed Tomography and Standard Electrocardiogram Provides Prognostic Information and Pathophysiological Insights in COVID-19 Pneumonia.胸部计算机断层扫描与标准心电图相结合可提供COVID-19肺炎的预后信息和病理生理学见解。
J Clin Med. 2021 Jul 7;10(14):3031. doi: 10.3390/jcm10143031.
为应对新冠疫情，心脏病学与机械通气重新接轨
JACC Case Rep. 2020 Jul 15;2(9):1402-1406. doi: 10.1016/j.jaccas.2020.03.007. Epub 2020 Mar 27.
4
Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action.新型冠状病毒肺炎患者的血栓栓塞风险和抗凝治疗：新出现的证据和行动呼吁。
Br J Haematol. 2020 Jun;189(5):846-847. doi: 10.1111/bjh.16727. Epub 2020 May 4.
5
The REVEAL Registry risk score calculator in patients newly diagnosed with pulmonary arterial hypertension.REVEAL 登记研究风险评分计算器在肺动脉高压初诊患者中的应用。
Chest. 2012 Feb;141(2):354-362. doi: 10.1378/chest.11-0676. Epub 2011 Jun 16.